ViH Articles

PCV59 Cost-Effectiveness of Dabigatran Etexilate Versus Apirin Plus Clopidogrel Combination in Stroke Prevention in Atrial Fibrillation (SPAF)- Russian Payer Perspective

Jun 1, 2012, 00:00
PSY53 Evaluation of Daily Average Consumption (DACON) of Oxycodone CR and Oxymorphone ER Using an Interrupted Time Series Analysis

Jun 1, 2012, 00:00
PCN58 A Comprehensive Cost-Effectiveness Analysis of Lenalidomide for Multiple Myeloma Patients who Have Received at Least One Prior Therapy

Jun 1, 2012, 00:00
PND56 Managed Care and Physician Perceptions of Novel Treatments in Multiple Sclerosis

Jun 1, 2012, 00:00
PMD18 Bypass Therapy Assay Testing As a Strategy to Reduce Treatment Costs for Hemophilia Patients with Inhibitors

Jun 1, 2012, 00:00
PHP70 E-Prescribing Trends in the United States- 2008-2012

Jun 1, 2012, 00:00
PRM50 Meta-Regression Models to Address Heterogeneity and Inconsistency in Network Meta-Analysis of Survival Outcomes

Jun 1, 2012, 00:00
PSY66 Use of Medicaid Analytic Extract for Evaluation of Drug Use and Health Services Utilization in Patients With Hemophilia

Jun 1, 2012, 00:00
PMH20 Factors Associated with Higher Health Care Resource Use among Patients with Bipolar Disorder- Results from a Large Multinational Longitudinal Study (WAVE-BD)

Jun 1, 2012, 00:00
PCN71 Cost Effectiveness Analysis of Busulfan + Cyclophosphamide (BuCy2) as Conditioning Regimen Before Allogeneic Human Steam Cell Transplantation (HSCT)- Comparison of Oral Versus IV Busulfan

Jun 1, 2012, 00:00
PCV23 Prevalence and Incidence of Atrial Fibrillation- An Analysis Based on 8.3 Million Patients

Jun 1, 2012, 00:00
PGI28 Proton Pump Inhibitor (Ppi) Prescribing Patterns, Ppi Costs, and Resource Utilization in a Nationally Representative Sample of Patients with Gastroesophageal Reflux Disease (GERD)

Jun 1, 2012, 00:00
PDB111 Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions- A Case Study in Type 1 Diabetes

Jun 1, 2012, 00:00
PGI14 Resource Utilization in Thrombocytopenia of Chronic Liver Diseases in the Veterans Affairs Population

Jun 1, 2012, 00:00
PIN17 Cost of Treatment Failure Among Adult Outpatients With Moderate or Complicated Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin Infections- A Starnet Study

Jun 1, 2012, 00:00
PHP56 An Analysis of Internal Medication Errors Using Incident Reports at a Teaching Hospital in Japan- A Retrospective Study

Jun 1, 2012, 00:00
PMD13 Assessing the Budget Impact of Using ScanBag® in CT in Six European Countries

Jun 1, 2012, 00:00
PHP36 Comprehensive Value Estimation of Adalimumab-Based Treatments- Covet Study

Jun 1, 2012, 00:00
PCV93 Market Response to Food and Drug Administration'S Safety Warnings- A Case Study Using an Interrupted Time Series Analysis of the Medicare Database for 2006-2008

Jun 1, 2012, 00:00
PSY24 Association of Patient Cost or Reimbursement Challenges With Health Care Resource Utilization, Quality of Life, and Work Productivity Among Patients With Inflammatory Bowel Disease

Jun 1, 2012, 00:00
PRS40 Measurement of Primary Medication Adherence among Children with Asthma Using Administrative Claims Data

Jun 1, 2012, 00:00
PUK7 Safety of Erythropoiesis-Stimulating Agents in Pediatric Patients with End Stage Renal Disease

Jun 1, 2012, 00:00
PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes

Jun 1, 2012, 00:00
PGI7 Factors Associated with Breakthrough Symptoms and OTC Use Among Gerd Patients in a Real-World Setting

Jun 1, 2012, 00:00
CE2 Comparative Effectiveness of Monotherapy With Mood Stabilizers Versus Atypical Antipsychotics for the Treatment of Bipolar Disorder in Children and Adolescents- A Retrospective Claims-Data Study

Jun 1, 2012, 00:00
PGI21 a Comparison of the Cost-Effectiveness of Fidaxomicin, Metronidazole, and Vancomycin, in the Treatment of Clostridium Difficile-Associated Disease

Jun 1, 2012, 00:00
PMH5 Association Between Second Generation Antipsychotics and Changes in Body Mass Index in Adolescents

Jun 1, 2012, 00:00
PRM13 Sensitivity Analysis in Cost-Effectiveness Analysis in Korea- A Review of Industry Submissions to HIRA

Jun 1, 2012, 00:00
PIH82 Health Care Screening and Preventive Practices among Women in the United States by Race/Ethnicity

Jun 1, 2012, 00:00
PRM26 Access to Real-World Databases in Europe – How to Find the One That Will Answer Your Research Question?

Jun 1, 2012, 00:00
PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions

Jun 1, 2012, 00:00
PMS30 Cost-Effectiveness of Bisphosphonates in Reducing Hip Fractures in the United States

Jun 1, 2012, 00:00
HC2 Association of Allergic Rhinitis with Asthma Exacerbations and Health Care Costs in Asthma Patients

Jun 1, 2012, 00:00
PCV65 Service Utilization, Predictors and Costs among High-Risk Patients with Cardiovascular Disease- Using Real World Data from the Australian Reach Registry

Jun 1, 2012, 00:00
PCV89 Patient-, Hospital-, and County- Level Predictors of Discharges and Readmissions among Patients with Cardiovascular Disease

Jun 1, 2012, 00:00
PSY35 Economic Evaluation of Lenalidomide in the Management of Previously Treated Multiple Myeloma (PTMM) Patients in Greece

Jun 1, 2012, 00:00
PMS15 Cost Analysis of Febuxostat Versus Allopurinol for Prophylaxis of Gout Flares

Jun 1, 2012, 00:00
PIH47 Symptoms and Management of Teething- Parents Reported Outcomes

Jun 1, 2012, 00:00
UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs- 1991-2008

Jun 1, 2012, 00:00
PCN34 Descriptive Costs of Chemotherapy Treatment for Stage 3 and Stage 4 Colon Cancer

Jun 1, 2012, 00:00
PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism- Analysis Based on Patient Reported Outcomes fro ...

Jun 1, 2012, 00:00
PND53 Discrepancies in Hospitalization Trends by Epilepsy Among Three Latin America Countries

Jun 1, 2012, 00:00
PRM56 Modeling the Progression of Chronic Diseases in a Dynamic Market- Implications for Budget Impact Analysis

Jun 1, 2012, 00:00
SB2 Comparative Effectiveness of On-Pump and Off-Pump Coronary Artery Bypass Grafting Among Elderly Patients – a Retrospective Analysis of Medicare Claims Data

Jun 1, 2012, 00:00
PCV74 The Relationship Between Hospital Readmission and Post-Discharge Medication Adherence

Jun 1, 2012, 00:00
PGI17 Societal Burden in Patients with Liver Transplantation- The Come Study Results

Jun 1, 2012, 00:00
PIH83 Health Technology Assessment in Child Health

Jun 1, 2012, 00:00
PRM48 Diagnostic Tools for the Assessment of the Underlying Model Assumptions in the Study of Health Care Costs

Jun 1, 2012, 00:00
PSS12 Economic Analysis of Etanercept as Continuous or Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Venezuela

Jun 1, 2012, 00:00
PMS49 Fatigue is an Independent Variable Predicting Physical Function and Das-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab- Results from a Phase 3, Placebo Controlled Clinical Trial

Jun 1, 2012, 00:00
PDB83 Diabetes Medication Usage Patterns in Geographies With High Hispanic Populations in the United States

Jun 1, 2012, 00:00
PMH35 Cost-Effectiveness of Agomelatine in Treatment of Major Depressive Disorders in Turkey

Jun 1, 2012, 00:00
PMD15 The Economic Burden of Atrial Fibrillation among Elderly Populations in Selected Developed Countries

Jun 1, 2012, 00:00
PCV67 Pharmacy Cost Sharing, Antiplatelet Therapy Utilization, and Health Outcomes for Patients with Acute Coroncary Syndrome

Jun 1, 2012, 00:00
PIN15 Impact of Surgical Staphylococcus Aureus Infections on US Hospitals

Jun 1, 2012, 00:00
PMD53 A Review of Health Technology Assessments (HTAS) for Cervical Cancer Screening Technologies

Jun 1, 2012, 00:00
PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis

Jun 1, 2012, 00:00
PCN5 Cancer During Pregnancy- Clinical and Economic Characteristics Associated With Inpatient Cases in the United States

Jun 1, 2012, 00:00
PCN15 A Longitudinal Review of Treatment Patterns in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) From Community Practice in the United States

Jun 1, 2012, 00:00
PSU6 Economic Impact of Using Sugammadex for the Reversal of Deep Neuromuscular Blockade in the Swedish Health Care Setting

Jun 1, 2012, 00:00
PRM36 International Comparisons of EQ-5D Health-States Valuations

Jun 1, 2012, 00:00
PCN4 Effect of Treatment Delays on Late-Stage Prostate Cancer Survival

Jun 1, 2012, 00:00
PSY47 Pharmacists' Beliefs Regarding Intention to Utilize Prescription Drug Monitoring Program (PDMP) Data

Jun 1, 2012, 00:00
PDB80 Effect of Diabetes Patient Characteristics on the Willingness-to-Pay for a New Basal Insulin – A Discrete Choice Experiment

Jun 1, 2012, 00:00
PCN147 Evaluating Contemporary Practice in Cml via a Retrospective Research Registry of Patients Across a Comprehensive Cancer Center Database

Jun 1, 2012, 00:00
PSS7 Health Care Costs and Utilization for Privately Insured Patients Treated for Non-Infectious Uveitis in the United States

Jun 1, 2012, 00:00
ISPOR 17th Annual International Meeting Financial Disclosure Information for Research Presentations

Jun 1, 2012, 00:00
PSU11 Comparing Robot-Assisted to Conventional Video-Assisted Thoracic Surgical (VATS)Lobectomy and Wedge Resection- Results from a Multi-Hospital (Premier) Database

Jun 1, 2012, 00:00
PCN87 Cost-Effectiveness of Hormone Therapies for ER+ Women with Early Breast Cancer in Canada- Exploring the Potential for the Cyp2D6 Genetic Test

Jun 1, 2012, 00:00
PCN89 Economic Evaluation of Erlotinib as Treatment of or Metastasic Cancer of Non-Small Cell Lung Cancer (NSCLC) Prior Chemotherapy in Mexico

Jun 1, 2012, 00:00
PMS17 Cost Minimization of Anti-TNF Biologics in the Treatment of Rheumatoid Arthritis, Akylosing Spondylitis and Psoriatic Arthritis in the Brazilian Public Health Care System

Jun 1, 2012, 00:00
PIN56 Rehospitalization and Costs Among Patients Treated With Linezolid Versus Vancomycin Following Hospitalization for Pneumonia in the Real-World Setting

Jun 1, 2012, 00:00
PRS53 Test-Retest Reliability of the Urticaria Patient Daily Diary in Electronic Format among Adults and Adolescents

Jun 1, 2012, 00:00
PGI3 Validation of Algorithms to Identify Diverticulitis Through Electronic Medical Records in Kaiser Permanente Southern California (KPSC)

Jun 1, 2012, 00:00
PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings

Jun 1, 2012, 00:00
PCN109 Progressive Worsening of Patient-Reported Outcomes in Untreated Patients With Myelofibrosis

Jun 1, 2012, 00:00
PUK24 Examining the Role of Caregiver Towards Blood Transfusion Decisions among Individuals with Chronic Kidney Disease

Jun 1, 2012, 00:00
PCN44 Examining the Cost of Chemotherapy Induced Nausea and Vomiting in Patients Treated for Cancer in a Medicaid Population

Jun 1, 2012, 00:00
PMD22 Comparative Cost Between Vertebroplasty and Kyphoplasty for the Treatment of Vertebral Compression Fractures

Jun 1, 2012, 00:00
PHP57 An Analysis of Intravenous Medication Errors Using Incident Reports at a Teaching Hospital in Japan

Jun 1, 2012, 00:00
PSU37 National Inpatient Burden Associated with Spinal Cord Injuries in the United States

Jun 1, 2012, 00:00
PND13 Economic Burden of Lennox-Gastaut Syndrome

Jun 1, 2012, 00:00
PIN33 Pharmacoeconomic Evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults

Jun 1, 2012, 00:00
PMS59 Burden of Disease in Women with Osteoporosis in Brazil- Results from 2011 National Health and Wellness Survey (NHWS)

Jun 1, 2012, 00:00
PMH38 Cost-Effectiveness of Asenapine in the Treatment of Schizophrenia in Canada

Jun 1, 2012, 00:00
PHP105 A Review of Different Approaches Proposed for Value Based Pricing

Jun 1, 2012, 00:00
PCN23 Incidence of Metastatic Hormone Receptor Positive (HR+) Breast Cancer in the United Kingdom (UK)- Data Needed!

Jun 1, 2012, 00:00
PMD33 Cost-Effectiveness of Molecular IgE in Vitro Diagnostics (IVD) in Children Suspected with Peanut Allergy Compared to Double Blind Placebo Controlled Food Challenge (DBPCFC) in EU, USA and Japan

Jun 1, 2012, 00:00
PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

Jun 1, 2012, 00:00
PHP25 Deriving Patient Chronic Disease Conditions From Medication Utilization Using Combination of Clinical Rules and Logistic Regression

Jun 1, 2012, 00:00
PRS48 The Trends of Child Obesity and the Effect of Child Obesity on Asthma in Young Children

Jun 1, 2012, 00:00
PMS26 Cost-Effectiveness of Denosumab Versus Oral Bisphosphonates in the United States for Post-Menopausal Osteoporosis (PMO)

Jun 1, 2012, 00:00
PMH23 Impact of Refill and Save Program on Adherence to Desvenlafaxine and Extended Release Venlafaxine HCl

Jun 1, 2012, 00:00
SB4 Propensity-Score Matching (PSM) to Control for Selection Bias in “Real-World” Treatment Comparisons- A Cautionary Tale Concerning Antibiotic Therapy for Infectious Disease

Jun 1, 2012, 00:00
PSS14 Economic Analysis of Etanercept as Paused Therapy in Moderate to Severe Psoriasis from a Public Perspective in Brazil

Jun 1, 2012, 00:00
PDB16 Treated to Glycemic Control Target Assessed by Fasting Plasma Glucose (Fpg) and Glycated Hemoglobin (Hba1C) in Patients With Type II Diabetes

Jun 1, 2012, 00:00
PUK21 Cost-Effectiveness Analysis of Solifenacin Succinate Versus Trospium Chloride in the Treatment of Patients with Overactive Bladder in Germany

Jun 1, 2012, 00:00
PCN75 Economic Evaluation of Bevacizumab for the Treatment of Advanced Ovarian Cancer in Mexico

Jun 1, 2012, 00:00
PCV22 Treatment Patterns and Outcomes in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension- Results of a Retrospective Chart Review in Six European Countries

Jun 1, 2012, 00:00
PCV83 Preliminary Assessment of the Utility of Short Performance Physical Battery (SPPB) and Ferrans and Power'S Quality of Life Questionnaire (QLI) in Advanced Heart Failure Patients

Jun 1, 2012, 00:00
PIN14 Resource Utilization and Costs of Treating Complicated Skin and Skin Structure Infections With Daptomycin or Telavancin

Jun 1, 2012, 00:00
PHP14 Federal Actions Involving Health Care Fraud and Abuse (2006-2010)

Jun 1, 2012, 00:00
PMH64 Anti-Anxiety Medication Utilization among Patients with Anxiety Disorder- Analysis of Medical Expenditure Panel Survey

Jun 1, 2012, 00:00
PDB84 Liberalization of Medical Savings Accounts for Outpatient Treatment and Health Care Utilization Among Type 2 Diabetes Mellitus Patients

Jun 1, 2012, 00:00
PRS23 Economic Analysis of Vorizonazole, Amphotericine B and Caspofungin for Invasive Aspergilosis Patients in Private Hospitals in Dominican Republic

Jun 1, 2012, 00:00
PMH76 Impact of Fda Black Box Warning on the Prescribing of Atypical Antipsychotics in Non-Institutionalized Dementia Patients

Jun 1, 2012, 00:00
Copyright/Subscription

May 1, 2012, 00:00
Agreement between Internet-Based Self- and Proxy-Reported Health Care Resource Utilization and Administrative Health Care Claims

May 1, 2012, 00:00
Table of Contents

May 1, 2012, 00:00
Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and the Friction Cost Approach

May 1, 2012, 00:00
Comparison of 7-Day Recall and Daily Diary Reports of COPD Symptoms and Impacts

May 1, 2012, 00:00
Simulated Value-Based Insurance Design Applied to Statin Use by Medicare Beneficiaries with Diabetes

May 1, 2012, 00:00
Instructions for Authors

May 1, 2012, 00:00
The EUROHIS-QOL 8-Item Index- Comparative Psychometric Properties to Its Parent WHOQOL-BREF

May 1, 2012, 00:00
QALY Weights for Diabetic Retinopathy—A Comparison of Health State Valuations with HUI-3, EQ-5D, EQ-VAS, and TTO

May 1, 2012, 00:00
Mapping the Functional Assessment of Cancer Therapy-General or -Colorectal to SF-6D in Chinese Patients with Colorectal Neoplasm

May 1, 2012, 00:00
Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

May 1, 2012, 00:00
On Discounting of Health Gains from Human Papillomavirus Vaccination- Effects of Different Approaches

May 1, 2012, 00:00
Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

May 1, 2012, 00:00
Handling Input Correlations in Pharmacoeconomic Models

May 1, 2012, 00:00
Editorial Board

May 1, 2012, 00:00
Efficacy of Once-Daily Indacaterol Relative to Alternative Bronchodilators in COPD- A Patient-Level Mixed Treatment Comparison

May 1, 2012, 00:00
A Review of Patient-Reported Outcome Labels in the United States- 2006 to 2010

May 1, 2012, 00:00
Reflections- NICE, Health Economics, and Outcomes Research

May 1, 2012, 00:00
Guidelines for Health Technologies- Specific Guidance for Oncology Products in Canada

May 1, 2012, 00:00
Tails from the Peak District- Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values

May 1, 2012, 00:00
Beyond the FDA PRO Guidan Steps toward Integrating Meaningful Patient-Reported Outcomes into Regulatory Trials and US Drug Labels

May 1, 2012, 00:00
Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine

May 1, 2012, 00:00
Decision-Making Criteria among National Policymakers in Five Countries- A Discrete Choice Experiment Eliciting Relative Preferences for Equity and Efficiency

May 1, 2012, 00:00
Do General Practitioners Know Patients' Preferences? An Empirical Study on the Agency Relationship at an Aggregate Level Using a Discrete Choice Experiment

May 1, 2012, 00:00
Australian Managed Entry Scheme- A New Manageable Process for the Reimbursement of New Medicines?

May 1, 2012, 00:00
A Reply to Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States

May 1, 2012, 00:00
Reasons for Rejection of Patient-Reported Outcome Label Claims- A Compilation Based on a Review of Patient-Reported Outcome Use among New Molecular Entities and Biologic License Applications, 2006–2010

May 1, 2012, 00:00
Condition-Specific Preference-Based Measures- Benefit or Burden?

May 1, 2012, 00:00
Exploring the Relationship between Alzheimer's Disease Severity and Longitudinal Costs

May 1, 2012, 00:00
Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure

May 1, 2012, 00:00
Guide for Authors

Mar 1, 2012, 00:00
Cost-Effectiveness Analysis of Collaborative Care Management of Major Depression among Low-Income, Predominantly Hispanics with Diabetes

Mar 1, 2012, 00:00
Patient Access to New Cancer Drugs in the United States and Australia

Mar 1, 2012, 00:00
Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder

Mar 1, 2012, 00:00
Cost-Effectiveness of Adjuvant FOLFOX Therapy for Stage III Colon Cancer in Japan Based on the MOSAIC Trial

Mar 1, 2012, 00:00
Resource Use, Costs, and Utility Estimates for Patients with Cystic Fibrosis with Mild Impairment in Lung Function- Analysis of Data Collected Alongside a 48-Week Multicenter Clinical Trial

Mar 1, 2012, 00:00
Incorporating Indirect Costs into a Cost-Benefit Analysis of Laparoscopic Adjustable Gastric Banding

Mar 1, 2012, 00:00
Prospective Observational Studies to Assess Comparative Effectiveness- The ISPOR Good Research Practices Task Force Report

Mar 1, 2012, 00:00
Learning Effects in Time Trade-Off Based Valuation of EQ-5D Health States

Mar 1, 2012, 00:00
Health-Related Quality of Life Measurement in Children and Adolescents in Ibero-American Countries, 2000 to 2010

Mar 1, 2012, 00:00
Estimating Preference-Based Single Index Measures for Dementia Using DEMQOL and DEMQOL-Proxy

Mar 1, 2012, 00:00
Editorial Board

Mar 1, 2012, 00:00
Quality-Adjusted Life Expectancies in Patients with Rheumatoid Arthritis—Comparison of Index Scores from EQ-5D, 15D, and SF-6D

Mar 1, 2012, 00:00
Lifetime Cost-Effectiveness of Skin Cancer Prevention through Promotion of Daily Sunscreen Use

Mar 1, 2012, 00:00
Comparative Effectiveness, Cost, and Utilization of Radical Prostatectomy among Young Men within Managed Care Insurance Plans

Mar 1, 2012, 00:00
Innovation and the Burden of Disease- Retrospective Observational Study of New and Emerging Health Technologies Reported by the EuroScan Network from 2000 to 2009

Mar 1, 2012, 00:00
Cost-Effectiveness of Different Strategies for Selecting and Treating Individuals at Increased Risk of Osteoporosis or Osteopenia- A Systematic Review

Mar 1, 2012, 00:00
Conducting Comparative Effectiveness Research on Medications- The Views of a Practicing Epidemiologist from the Other Washington

Mar 1, 2012, 00:00
Antihypertensive Drugs- A Perspective on Pharmaceutical Price Erosion and Its Impact on Cost-Effectiveness

Mar 1, 2012, 00:00
Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients

Mar 1, 2012, 00:00
A Review of the Cost of Atrial Fibrillation

Mar 1, 2012, 00:00
Informing Shared Decisions about Advance Directives for Patients with Severe Chronic Obstructive Pulmonary Disease- A Modeling Approach

Mar 1, 2012, 00:00
Patient Access to New Cancer Drugs in the United States and Australia—Reply to Letter to the Editor by Dr. Wonder

Mar 1, 2012, 00:00
Comparison of FACT- and EQ-5D–Based Utility Scores in Cancer

Mar 1, 2012, 00:00
Pharmaceutical Cost-Containment Policies and Sustainability- Recent Irish Experience

Mar 1, 2012, 00:00
Improving the Measurement of QALYs in Dementia- Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis

Mar 1, 2012, 00:00
Copyright/Subscription

Mar 1, 2012, 00:00
Can Observational Studies Approximate RCTs?

Mar 1, 2012, 00:00
Table of Contents

Mar 1, 2012, 00:00
Priority Symptoms in Advanced Breast Cancer- Development and Initial Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16)

Jan 1, 2012, 00:00
Impact of the Introduction of Government Use Licenses on the Drug Expenditure on Seven Medicines in Thailand

Jan 1, 2012, 00:00
Copyright/Subscription

Jan 1, 2012, 00:00
Extension of Kaplan-Meier Methods in Observational Studies with Time-Varying Treatment

Jan 1, 2012, 00:00
Evidence to Inform Decision Makers in Thailand- A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis

Jan 1, 2012, 00:00
Eliciting Public Preference for Health-Care Resource Allocation in South Korea

Jan 1, 2012, 00:00
Copyright/Subscription

Jan 1, 2012, 00:00
Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses- Application in Rheumatoid Arthritis

Jan 1, 2012, 00:00
Modeling Cost-Effectiveness of Cervical Cancer Screening in Hungary

Jan 1, 2012, 00:00
Erratum

Jan 1, 2012, 00:00
The Effects of Medication Supply on Hospitalizations and Health-Care Costs in Patients with Chronic Heart Failure

Jan 1, 2012, 00:00
Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model- Comparing Two Antipsychotics in the Treatment of Schizophrenia

Jan 1, 2012, 00:00
The Performance of a Value Set for the EQ-5D Based on Experienced Health States in Patients with Inflammatory Bowel Disease

Jan 1, 2012, 00:00
Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea

Jan 1, 2012, 00:00
Bridging the Gap in Pharmacoeconomics and Outcomes Research between Researchers, Policymakers, and Practitioners in the Asia-Pacific Region

Jan 1, 2012, 00:00
Direct Cost Analysis of Intensive Care Unit Stay in Four European Countries- Applying a Standardized Costing Methodology

Jan 1, 2012, 00:00
Modeling the Effects of H1N1 Influenza Vaccine Distribution in the United States

Jan 1, 2012, 00:00
Cost-Effectiveness of Nonpharmacologic, Nonsurgical Interventions for Hip and/or Knee Osteoarthritis- Systematic Review

Jan 1, 2012, 00:00
3rd Special Issue- Pharmacoeconomics Outcomes Research in Asia

Jan 1, 2012, 00:00
Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea

Jan 1, 2012, 00:00
Instructions for Authors

Jan 1, 2012, 00:00
The Role of the Expected Value of Individualized Care in Cost-Effectiveness Analyses and Decision Making

Jan 1, 2012, 00:00
Reviewer Acknowledgement

Jan 1, 2012, 00:00
Further Validation of the Uterine Fibroid Symptom and Quality-of-Life Questionnaire

Jan 1, 2012, 00:00
ISPOR Code of Ethics

Jan 1, 2012, 00:00
Evidence-Based Prediction of Statin Use with Lipid-Panel Data from the National Health and Nutrition Examination Survey

Jan 1, 2012, 00:00
Stated Preferences of Physicians and Chronic Pain Sufferers in the Use of Classic Strong Opioids

Jan 1, 2012, 00:00
Clinical and Economic Outcomes Associated with Adjuvant Chemotherapy in Elderly Patients with Early Stage Operable Breast Cancer

Jan 1, 2012, 00:00
Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries

Jan 1, 2012, 00:00
The Cost-Effectiveness of Different Chemotherapy Strategies for Patients with Poor Prognosis Advanced Colorectal Cancer (MRC FOCUS)

Jan 1, 2012, 00:00
Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan- A Transmission Dynamic Modeling Approach

Jan 1, 2012, 00:00
Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan

Jan 1, 2012, 00:00
Feasibility and Construct Validity of PROMIS and “Legacy” Instruments in an Academic Scleroderma Clinic

Jan 1, 2012, 00:00
Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting- A Health Economic Model Based on the PREDICTIVE Study

Jan 1, 2012, 00:00
Comparing Methods for Identifying Future High-Cost Mental Health Cases in Medicaid

Jan 1, 2012, 00:00
Editorial Board

Jan 1, 2012, 00:00
Table of Contents

Jan 1, 2012, 00:00
Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and Malaysia

Jan 1, 2012, 00:00
Health Utility Measured with EQ-5D in Thai Patients Undergoing Peritoneal Dialysis

Jan 1, 2012, 00:00
Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand

Jan 1, 2012, 00:00
Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases- A Simulation Cohort Study

Jan 1, 2012, 00:00
Table of Contents

Jan 1, 2012, 00:00
Cost-Effectiveness of Maintenance Pemetrexed in Patients with Advanced Nonsquamous-Cell Lung Cancer from the Perspective of the Swiss Health Care System

Jan 1, 2012, 00:00
Economic Implications of the Dynamic Relationship between Antibiotic Use and Hospital-Acquired Infections

Jan 1, 2012, 00:00
An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore

Jan 1, 2012, 00:00
Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India

Jan 1, 2012, 00:00
Guide for Authors

Jan 1, 2012, 00:00
The Burden of Illness for Patients with Viral Hepatitis C- Evidence from a National Survey in Japan

Jan 1, 2012, 00:00
A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan

Jan 1, 2012, 00:00
Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea

Jan 1, 2012, 00:00
Availability, Health-Care Costs, and Utilization Patterns of Biologics in Taiwan

Jan 1, 2012, 00:00
Reviewing the Cost-Effectiveness of Endocrine Early Breast Cancer Therapies- Influence of Differences in Modeling Methods on Outcomes

Jan 1, 2012, 00:00
Delisting Policy Reform in South Korea- Failed or Policy Change?

Jan 1, 2012, 00:00
Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods

Jan 1, 2012, 00:00
Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand

Jan 1, 2012, 00:00
A Review of Generic Preference-Based Measures of Health-Related Quality of Life in Visual Disorders

Jan 1, 2012, 00:00
Impact of Secondary Cardiovascular Events on Health Status

Jan 1, 2012, 00:00
Drug Reimbursement Decision-Making in Thailand, China, and South Korea

Jan 1, 2012, 00:00
The MacNew Heart Disease Health-Related Quality of Life Questionnaire in Patients with Angina and Patients with Ischemic Heart Failure

Jan 1, 2012, 00:00
National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia- Drug Listing Changes and Opportunities

Jan 1, 2012, 00:00
Editorial Board

Jan 1, 2012, 00:00
Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens- Combined Results of Two German Self-Report Surveys

Dec 1, 2011, 00:00
Prioritizing Pharmacogenetic Research- A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment

Dec 1, 2011, 00:00
Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis

Dec 1, 2011, 00:00
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 2—Assessing Respondent Underst ...

Dec 1, 2011, 00:00
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil

Dec 1, 2011, 00:00
Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C

Dec 1, 2011, 00:00
Methods for Using Data Abstracted from Medical Charts to Impute Longitudinal Missing Data in a Clinical Trial

Dec 1, 2011, 00:00
Social Valuation of EQ-5D Health States- The Chilean Case

Dec 1, 2011, 00:00
Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease

Dec 1, 2011, 00:00
Effect of Health-Related Quality-Of-Life Instrument and Quality-Adjusted Life Year Calculation Method on the Number of Life Years Gained in the Critical Care Setting

Dec 1, 2011, 00:00
Elicitation of Informed General Population Health State Utility Values- A Review of the Literature

Dec 1, 2011, 00:00
When Evaluating Parameter Uncertainty Is Not Enough- The Case of Dasatinib and Nilotinib for Imatinib-Resistant Chronic Myeloid Leukemia

Dec 1, 2011, 00:00
Guide for Authors

Dec 1, 2011, 00:00
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation- ISPOR PRO Good Research Practices Task Force Report- Part 1—Eliciting Concepts for a New ...

Dec 1, 2011, 00:00
DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries

Dec 1, 2011, 00:00
Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research- How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size

Dec 1, 2011, 00:00
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

Dec 1, 2011, 00:00
Editorial Board

Dec 1, 2011, 00:00
Assuring the Patient Centeredness of Patient-Reported Outcomes- Content Validity in Medical Product Development and Comparative Effectiveness Research

Dec 1, 2011, 00:00
Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa- Estimates Based on DART Trial Results and Costs for Uganda and Kenya

Dec 1, 2011, 00:00
Response Burden and Questionnaire Length- Is Shorter Better? A Review and Meta-analysis

Dec 1, 2011, 00:00
Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa- Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falci ...

Dec 1, 2011, 00:00
Copyright/Subscription

Dec 1, 2011, 00:00
Cost-Utility Analyses of Diagnostic Laboratory Tests- A Systematic Review

Dec 1, 2011, 00:00
Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease- A US Payer Perspective

Dec 1, 2011, 00:00
Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire

Dec 1, 2011, 00:00
Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer- A Discrete Choice Experiment

Dec 1, 2011, 00:00
Reviewer Acknowledgment

Dec 1, 2011, 00:00
EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children- A Systematic Methodological Review

Dec 1, 2011, 00:00
The National Institute for Health and Clinical Excellence Single Technology Appraisal Process- Lessons from the First 4 Years

Dec 1, 2011, 00:00
Estimating Population-Based Values for EQ-5D Health States in Thailand

Dec 1, 2011, 00:00
Table of Contents

Dec 1, 2011, 00:00
PCN103 The Adjuvant Treatment of Stage 3 Colon Cancer (aCC)- An Indirect Cost-Minimisation and Population Net Health Benefit Analysis of Capecitabine + Oxaliplatin (XELOX) vs. iv 5-FU + FA + Oxaliplatin (FOLFOX)

Nov 1, 2011, 00:00
HG1 Applying Frailty Model in Longitudinal Survivals of Chronic Diseases

Nov 1, 2011, 00:00
PCN100 A Cost–Utility Analysis of Degarelix in the Treatment of Advanced Hormone-Dependent Prostate Cancer in Scotland

Nov 1, 2011, 00:00
PCV1 Explorative Analysis about the Appropriateness of a GPS Longitudinal Database on Evaluating Atypical Antipsychotics in Terms of Drugs Adverse Events

Nov 1, 2011, 00:00
PMS24 The Cost of Care of Rheumatoid Arthritis and Ankylosing Spondylitis Patients in Tertiary Care Rheumatology Units in Turkey

Nov 1, 2011, 00:00
PIN1 Pharmacist Participation in Antiretroviral Drug Monitoring for the Prevention of Mother-to-Child Transmission of HIV at Warinchumrab Hospital, Ubonratchathani, Thailand

Nov 1, 2011, 00:00
PDB62 The Impact of Clinical Inertia in the Treatment of Type 2 Diabetes

Nov 1, 2011, 00:00
TP2 Patrones De Tratamiento De La Leucemia Mieloide Crónica (Lmc) En Pacientes Resistentes O Intolerantes A Imatinib En Instituciones De Salud Pública En México

Nov 1, 2011, 00:00
UT2 Update of The Patient-Reported Outcome And Quality Of Life Instruments Database (PROQOLID) Using The FDA Guidance On Pro Measures

Nov 1, 2011, 00:00
NI2 The Impact of Nice Guidance on the Diffusion of Medical Devices

Nov 1, 2011, 00:00
PHP102 Biosimilars- Pricing Reimbursement in Germany- Key Insights From Sickness Funds

Nov 1, 2011, 00:00
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell Carcinoma

Nov 1, 2011, 00:00
PIN7 COST-Effectiveness Analysis Of Anti-Pneumococcal Vaccines Versus No Vaccination In El Salvador

Nov 1, 2011, 00:00
PSU20 Estimating Preferences for Economic Evaluation in Patients with Localized Prostate Cancer

Nov 1, 2011, 00:00
PIH20 the Burden of Endometriosis- Costs and Quality of Life of Women with Endometriosis Treated in Referral Centres

Nov 1, 2011, 00:00
PHP22 Use of Decision Modeling to Estimate the Negative Impact of Tobacco Use on Health Care Costs and Health Disparities in People Living with HIV

Nov 1, 2011, 00:00
PDB39 Cost-Effectiveness of Saxagliptin Compared to Sitagliptin for the Treatment of Patients with Type 2 Diabetes Mellitus (T2DM)

Nov 1, 2011, 00:00
PSU18 Cost-Utility Analysis of Laparoscopic Versus Open Surgery for Colorectal Cancer

Nov 1, 2011, 00:00
PCV104 Persistence in Hypertension Treatment with Olmesartan Medoxomil Versus Valsartan - Analysis of Real-Life Prescription Data in Germany

Nov 1, 2011, 00:00
PGI15 The Cost and Quality of Life of Hepatitis C in the Netherlands

Nov 1, 2011, 00:00
PSY46 Comparison of Eq-5D and Sf-6D Utilities in Pompe Disease

Nov 1, 2011, 00:00
PMH58 Donepezil Oral Disintegrating Versus Donepezil Standard Tablets on Objective Burden of Caregivers of NaÏve Patients with Alzheimer'S Disease

Nov 1, 2011, 00:00
PMS3 Differentiation of Osteoporosis Treatments Action on Bone Remodeling- Principal Components Analysis of Bone Histomorphometry Parameters

Nov 1, 2011, 00:00
PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American Countries

Nov 1, 2011, 00:00
PIN9 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C Treatment

Nov 1, 2011, 00:00
PHP85 A Systematic Review of Automated Dose Dispensing in Primary Health Care

Nov 1, 2011, 00:00
PRM45 Importance of Collaboration with Developers in the Clarification of Concepts- A Case Study with the University of California, San Diego (UCSD) Shortness of Breath Questionnaire (SOBQ)

Nov 1, 2011, 00:00
PDB52 Adherence with Oral Medications for Diabetes Among Brazilian Patients- A Systematic Review of National Literature

Nov 1, 2011, 00:00
PHP19 Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition in the OECD?

Nov 1, 2011, 00:00
PIN70 Modelling the Epidemiological Impact of Rotavirus Vaccination to Assess its Cost-Effectiveness in England and Wales

Nov 1, 2011, 00:00
PND65 Describing and Comparing Utility from EQ-5D and SF-6D in A Huntington'S Disease Population

Nov 1, 2011, 00:00
PCN96 Costs of Adjuvant Chemotherapy with Oxaliplatin in Stage III Colon Cancer- Comparing the Three Schemes Standards- FOLFOX-4, FLOX and XELOX

Nov 1, 2011, 00:00
PRS52 Inpatient Hospital Care or Hospital-At-Home for COPD Exacerbations- A Discrete Choice Experiment

Nov 1, 2011, 00:00
PCV40 Budget Impact Model After the Introduction of Vernakalant in Spain

Nov 1, 2011, 00:00
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary Disease

Nov 1, 2011, 00:00
PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis- Comparative Results From 5 European Countries

Nov 1, 2011, 00:00
PMH48 The Spanish Version of the Clinically Useful Depression Outcome Scale- A Valid Instrument to Evaluate Depressive Symptoms in Primary Care

Nov 1, 2011, 00:00
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on ...

Nov 1, 2011, 00:00
PRS22 Estimation of Direct and Inderct Costs of COPD in Ukraine- The Pilot Study Results

Nov 1, 2011, 00:00
PCV71 Sponsorship and Pharmacoeconomic Conclusions of Studies on Statin Use for Cardiovascular Prevention- A Systematic Analysis

Nov 1, 2011, 00:00
PHP158 Determining the Monetary Value of a Quality-Adjusted Life Year (QALY)- Systematic Review of the Evidence

Nov 1, 2011, 00:00
PHP28 Drugs for Rare Diseases- Influence of Oprhan Designation Status on Price

Nov 1, 2011, 00:00
PMH67 Drug Utilisation Adaptations in Sweden After the Effexor Patent Expiry

Nov 1, 2011, 00:00
PMD33 Economic Evaluation of Two Wound Dressings for Children with Partial-Thickness Scalds from the Public Payer Perspective

Nov 1, 2011, 00:00
PCV3 Estimated Cost of Acute Coronary Syndrome for 2011- Case of Brazil

Nov 1, 2011, 00:00
PDB41 The Cost-Effectiveness of Getting to Glucose, Blood Pressure, and Lipid Goals in Patients Newly Diagnosed with Type 2 Diabetes Mellitus (T2DM) and Younger Than Fifty in Sweden

Nov 1, 2011, 00:00
PGI14 Resource Use and Cost of Hepatitis C Related Care in Belgium

Nov 1, 2011, 00:00
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World Data

Nov 1, 2011, 00:00
RS2 Cost-Effectiveness of End-of-Life, Life-Extending Interventions- NICE's Cost-Effectiveness Threshold Explored

Nov 1, 2011, 00:00
PSY56 Effect of Worksite Weight Management Program on Workers Productivity

Nov 1, 2011, 00:00
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United States

Nov 1, 2011, 00:00
PIH38 Self Reported Health Status and Quality of Life Among Coastal Rural Population in South India

Nov 1, 2011, 00:00
PCV51 Cost of Acute Coronary Syndrome in Switzerland

Nov 1, 2011, 00:00
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the Elderly

Nov 1, 2011, 00:00
ISPOR 3rd Latin America Conference Research Abstracts Author Index

Nov 1, 2011, 00:00
PMH49 Development and Content Validity of a Patient Reported Outcomes Measure to Assess Symptoms of Major Depressive Disorder (MDD)

Nov 1, 2011, 00:00
PRS37 The Impact of Regional Data on Cost-Effectiveness Results of Salmeterol/Fluticasone Propionate (SAL/FP) + Fenoterol/Ipratropium Bromide (Fen/IB) Versus Fen/IB Only in COPD Treatment

Nov 1, 2011, 00:00
PRS9 Budget Impact Analysis Of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

Nov 1, 2011, 00:00
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life- Final Results

Nov 1, 2011, 00:00
PCN78 Review of the Recent Pharmaceutical Additions to the Treatment of Colorectal Cancer

Nov 1, 2011, 00:00
PRS43 Pharmacoeconomic Evaluation of Antibiotic Therapy of Community-Acquired Infections of the Lower Respiratory Tracts By the Use of Moxifloxacin Versus Clarithromycin in Ukraine

Nov 1, 2011, 00:00
CV4 Cost-Effectiveness of Implantable Cardioverter-Defibrillator in Patients With Risk Factors for Sudden Death in Argentina

Nov 1, 2011, 00:00
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)

Nov 1, 2011, 00:00
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal Origin

Nov 1, 2011, 00:00
PDB38 Economic Evaluation of Ranibizumab in the Treatment of Visual Impairment Due to Diabetic Macular Edema in Austria

Nov 1, 2011, 00:00
PIN87 Hepatitis C Treatment Continuation Rates in Treatment-Naïve Genotype 1 Patients in the Brazilian Public Health Care System

Nov 1, 2011, 00:00
PCV24 Pharmacoepidemiology and Pharmacoeconomic Aspects of Use of ACE Inhibitors in Serbia Compared with Montenegro in 2009

Nov 1, 2011, 00:00
PCV22 Geographic Variation Trends in Critical Limb Ischemia Prevalence in the United States

Nov 1, 2011, 00:00
PCN57 Cost of Treatment of Multiple Myeloma in Ukraine

Nov 1, 2011, 00:00
PCN179 Clinical Trials in Oncology in Greece

Nov 1, 2011, 00:00
PGI31 The Maintenance of Work-related Productivity During One Year of MMX Mesalamine Treatment for Patients with Quiescent Ulcerative Colitis

Nov 1, 2011, 00:00
PHP106 when is Lower Level Evidence of Effectiveness Acceptable in Reimbursement Decisions?- A Decision Algorithm to Guide Policy Makers

Nov 1, 2011, 00:00
PCV80 Economic Evaluation of Pravastatin for the Prevention of Coronary Artery Disease in Japan

Nov 1, 2011, 00:00
PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care Setting

Nov 1, 2011, 00:00
PCN134 Patient Preferences for Non-Small Cell Lung Cancer (NSCLC) Treatments

Nov 1, 2011, 00:00
PCV122 How Patients with Chronic Stable Angina Perceive and Live with their Disease on an Everyday Basis?

Nov 1, 2011, 00:00
PMD50 Cost-Effectiveness of Cardiac resynchronisation therapy for Patients with Moderate-to-Severe Heart Failure

Nov 1, 2011, 00:00
PMS63 New Developments in the Ankylosing Spondylitis Quality of Life (ASQOL) Scale

Nov 1, 2011, 00:00
PIH37 The Royal Road or the Middle Way? Public and Patient Preferences for Health Outcomes

Nov 1, 2011, 00:00
PCN186 An Epidemiological Evaluation of Chemotherapy Used in the Treatment of Metastatic Prostate Cancer

Nov 1, 2011, 00:00
PIN82 Cost-Effectiveness of Atazanavir/R Compared to Darunavir/R in Germany

Nov 1, 2011, 00:00
PIH10 Examination of Female Balance Maintenance Ability in Major Life Stages

Nov 1, 2011, 00:00
PMH54 Quality of Life as a Predictor of Clinical Outcome- Example in Schizophrenia

Nov 1, 2011, 00:00
PRS19 Quality of Life and Economics of Asthma Control in France and Spain- Final Results of the EU-Coast Study

Nov 1, 2011, 00:00
PHP69 Can We Increase Hospital Revenue with Different Neuromuscular Blockers? An Analysis of Saving Cost for Hospital Budget with Time Saving Effect of Different Neuromuscular Blockers in Short Operations

Nov 1, 2011, 00:00
PCV147 Framingham Risk Score in Health Economic Modelling- A European Perspective

Nov 1, 2011, 00:00
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in Spain

Nov 1, 2011, 00:00
PHP118 Analysis of Pricing Reimbursement Approval Process for New Drugs in Korea Under Newly-Introduced HTA Environment (2007-2010)

Nov 1, 2011, 00:00
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric Bypass

Nov 1, 2011, 00:00
PCV97 Cost-Effectiveness Analysis of Public Health Interventions to Prevent Obesity in New Zealand

Nov 1, 2011, 00:00
PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

Nov 1, 2011, 00:00
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (AE) Departments

Nov 1, 2011, 00:00
PSS1 Ocular Discomfort, Compliance and Intra-Ocular Pressure (Iop) Control in Patients Treated for Glaucoma

Nov 1, 2011, 00:00
PHP55 A Review of the Nice Appeals Process

Nov 1, 2011, 00:00
PCN136 Cancer Patients' Perceptions Towards the Integration of Traditional CM) into the Conventional Cancer Treatment- A Qualitative Insight

Nov 1, 2011, 00:00
PHP115 Preliminary Analysis of the Unwritten Decision Rules Behind the French Transparency Commission'S Assessment of Drugs

Nov 1, 2011, 00:00
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro social

Nov 1, 2011, 00:00
PCN164 Does Different Availability of Oncology Care is Responsible for Differences in Cancer-related Mortality Rates Among the Provinces of Poland?

Nov 1, 2011, 00:00
PCN154 Discussing the Introduction of National Screening Programs in Gree A Delphi Study

Nov 1, 2011, 00:00
PRM33 Systematic Review of Health State Utilities in Spain

Nov 1, 2011, 00:00
PMD51 Cost Savings and Improved Utility through the Use of Florbetaben Beta-Amyloid PET Imaging in Dementia Diagnosis

Nov 1, 2011, 00:00
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic Rhinoconjunctivitis

Nov 1, 2011, 00:00
PRM21 Validating a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision Making

Nov 1, 2011, 00:00
PCN53 Economic Burden of HPV-Related Head Neck and Anal Cancers in Germany

Nov 1, 2011, 00:00
PSS27 We Treat Eyes, Not People- The Systematic Overestimations of Utility in Age-Related Macular Degeneration Models

Nov 1, 2011, 00:00
PCV31 Cerebral Hemorrhage and Transient Ischemic Attack Affected by Meteorological Factors

Nov 1, 2011, 00:00
PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes Treatments

Nov 1, 2011, 00:00
VI1 Determining the Impact of Modeling Additional Sources of Uncertainty in Value of Information Analysis

Nov 1, 2011, 00:00
PIN95 The Impact of Influenza on In- and Outpatients' Health related Quality of Life During the Pandemic Season 2009-2010 in Spain

Nov 1, 2011, 00:00
PCN146 Good Prognosis, Good Quality of Life? – Longitudinal Assessment of Quality of Life in Thyroid Cancer Patients

Nov 1, 2011, 00:00
PMD8 Systematic Review of the Impact Different Metal Femoral Stems (MFSS) Have on Patient outcomes in total Hip replacement (THR) Due to Osteoarthritis (OA)

Nov 1, 2011, 00:00
PRS29 Evaluation of Stable COPD Medication Costs in Ukraine Based on GPS' Prescriptions Habits Survey Results

Nov 1, 2011, 00:00
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple Sclerosis

Nov 1, 2011, 00:00
PCV129 Discrepancies Between Defined Daily Doses and Actual Prescription Patterns in the Polish Setting- the ACE Inhibitors Example

Nov 1, 2011, 00:00
PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in Portugal

Nov 1, 2011, 00:00
PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?

Nov 1, 2011, 00:00
PND24 Cost of Symptomatic Drug Therapy in Multiple Sclerosis

Nov 1, 2011, 00:00
PGI9 Impact of Dysphagia on U.S. Hospital Charges in Patients with Comorbid Conditions

Nov 1, 2011, 00:00
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) Population

Nov 1, 2011, 00:00
PMH23 The Economic Burden of Mental Ill Health in the Workpla A Costing Approach for Brazilian Employers

Nov 1, 2011, 00:00
PCV114 Preferences for Communication Outcomes Following a Stroke

Nov 1, 2011, 00:00
PCN197 Health Related Quality of Life in Long Term Survivors of Lymphoma- A Population Based Study

Nov 1, 2011, 00:00
PR2 The Beauty of Mapping- Need the Mean Health-Related Quality of Life Score for a Group of Hip Patients and Don't Have EQ-5D? Just Use the Oxford Hip Score!

Nov 1, 2011, 00:00
PRS3 Costos De atencion Medica De La Enfermedad Pulmonar Obstructiva Cronica atribuibles Al Tabaco

Nov 1, 2011, 00:00
PHP16 Extrapolating Strategic Insights Through Market Segmentation- A Conceptual Framework

Nov 1, 2011, 00:00
MO3 A Methodological Framework for Developing Models of Whole Disease Areas to Inform Resource Allocation Decisions

Nov 1, 2011, 00:00
PSY38 Estimating Healthy-Time Equivalents for Migraine Treatment Outcomes from Conjoint Analysis Measures of Patient Preferences

Nov 1, 2011, 00:00
PHP78 Convergent Tendencies in Budget Impact Analysis Across Europe and Beyond- Germany - Don'T Lose out on the “Zeitgeist”!

Nov 1, 2011, 00:00
PHP91 Patient Safety Activities Associated with Hospital Pharmacy in A Nationwide Survey on Management System for Patient Safety

Nov 1, 2011, 00:00
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech Republic

Nov 1, 2011, 00:00
PGI10 Analysis of Originator Versus Generic Prescribing of Proton Pump Inhibitors

Nov 1, 2011, 00:00
PCN25 Budget Impact Analysis of Switching to Digital Mammography in A Breast Cancer Population-Based Screening Program

Nov 1, 2011, 00:00
PDB60 Health Related Quality of Life of Diabetics in Sindh

Nov 1, 2011, 00:00
PIN64 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in Guatemala

Nov 1, 2011, 00:00
PHP31 Analisis Costo Efectividad Sectorial De 45 Intervenciones Sanitarias En Chile

Nov 1, 2011, 00:00
PMS71 A Population Based Assessment of Osteoporosis Prevalence and Treatment in Primary Health Care in Madrid (Spain)

Nov 1, 2011, 00:00
PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple Sclerosis

Nov 1, 2011, 00:00
PIH3 Resource Use And Associated Costs For The Treatment Of Heavy Menstrual Bleeding With Levonorgestrel Releasing Intrauterine System (LNG-IUS) Versus Hysterectomy- The Brazilian Public Healthcare System (SUS) Perspective

Nov 1, 2011, 00:00
PRM5 Incorporating Equity Into Developing and Implementing Evidence-Based Clinical Practice Guidelines

Nov 1, 2011, 00:00
PMH1 Comparing The Effectiveness Of Paliperidone Palmitate Versus Olanzapine Pamoate For Relapse Prevention In Schizophrenia- Post Hoc Indirect Analysis Using Published Placebo-Controlled Studies

Nov 1, 2011, 00:00
PIH56 Performance Assessment of Ga District Mutual Health Insurance Scheme in the Greater Accra Region in Ghana

Nov 1, 2011, 00:00
PHP140 “Troica” Health Care Economics in Greece

Nov 1, 2011, 00:00